Dr. Kahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
35 Park St
New Haven, CT 06511
Education & Training
- University of ConnecticutResidency, Internal Medicine, 2018 - 2021
- Federal University of Bahia Faculty of MedicineClass of 2010
Certifications & Licensure
- CT State Medical License 2018 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Merit Award Recipient, Cancer Survivorship Symposium ASCO, 2018
- Laureate Award fora Medical Student Federal University of Bahia School of Medicine, 2011
- Honorable Mention, Poster UFBA, 2008
- Join now to see all
Publications & Presentations
PubMed
- Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer.Julia Foldi, Kim R M Blenman, Michal Marczyk, Vignesh Gunasekharan, Alicja Polanska
Breast Cancer Research and Treatment. 2024-11-01 - 1 citationsTrends in breast cancer specific death by clinical stage at diagnoses between 2000-2017.Michal Marczyk, Adriana Kahn, Andrea Silber, Mariya Rosenblit, Michael P Digiovanna
Journal of the National Cancer Institute. 2024-09-30 - 3 citationsNavigating the Complexities of Brain Metastases Management.Afsaneh Amouzegar, Shannon Haig, Adriana M Kahn, Hussein A Tawbi, Joshua A Jones
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01
Journal Articles
- Clinical impact of adjuvant radiotherapy delay after neoadjuvant chemotherapy inlocally advanced breast cancerBrito S, Pereira AA, Medeiros KA, Brasileiro VJ, Matutino, A, Leonardi MCA, Velame R, Viveiros PH, Lima J, Filassi D, Carvalho H,Piato JR, Mano,MS, Breast, 1/1/2018
- Prophylactic cranial irradiation for extensive stage small cell lung cancer � a retrospective analysisMatutino ARB, Mak MP, Takahashi TK, Fraile NMP, Bitton RC, Nakazato D, Guimaraes RGR, Gabrielli FCG, Vasconcelos KGMC, Carvalho HA, Castro-Junior G, Journal of Global Oncology, 1/1/2017
- Safety and Efficacy of a Modified FLOX Adjuvant Regimenfor Patients With Stage III Colorectal Cancer Treated in the CommunityProtasio BM, MatutinoA, Lage LV, SantanaI,Ramos R,Sabbaga J,CapareliF,SaragiottoD, RiechelmannR,HoffPM, ClinColorectal Cancer, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Lymphoma-Associated Pulmonary Embolism Burden in Hospital Admissions in the United StatesAdriana Kahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The impact of age in the quality of life of patients diagnosed with breast cancer after curative treatment.Matutino A, Lewis J, HuberS, TaylorA, ChenG, Verma S, ASCO Cancer Survivorship Symposium: Advancing Care and Research, 1/1/2018
- Complete Pathologic Response as a Prognostic Factor in Breast Cancer: The Experience of a Brazilian Cancer Reference Center.MatutinoARB, Lima JMS, Silva SB, Silva-JuniorAA,Fraile NMP,Boas,MSV,StephanBO, Vaisberg VV, Pereira AAL, Mano MS, Clinical Oncology Brazilian Society Meeting, 1/1/2015
- Join now to see all
Lectures
- Clinical characteristics and survival of lung cancer patients according to insurance status prior to and post the implementation of the Affordable Care Act.Atlanta, GA - 1/1/2018
- Survivorship Care in Breast Cancer: Transitioning from Cancer Centres to Family Physicians.Calgary, Canada - 1/1/2017
- Crizotinib for advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements: a 4-year Canadian center experience.Calgary, Canada, 2017; Atlanta, GA, 2017 - 1/1/2017
- Join now to see all
Press Mentions
- Study: Patient’s Genetic Characteristics May Help Differentiate HER2-Low Advanced Breast Cancers and Guide Treatment SelectionDecember 9th, 2023
- Yale Cancer Center Experts Present New Research at Leading Breast Cancer SymposiumDecember 20th, 2023
- Breast Cancer Highlights from ASCO 2024June 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: